lymphadenectomy
rcts and quasi - rcts that compared lymphadenectomy versus no lymphadenectomy in adult women diagnosed with endometrial cancer .
to evaluate the effectiveness and safety of lymphadenectomy for the management of endometrial cancer .
lymphadenectomy in the management of stage i malignant melanoma: a prospective randomized study .
[ lymphadenectomy: indications - - technic - - invasion - - documentation ] .
postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. - pubmed - ncbi
sentinel node biopsy with lymphadenectomy - karenzupko & associates, inc. karenzupko & associates, inc .
sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis .
to compare the performance of sentinel lymph node (sln) mapping with staging lymphadenectomy versus staging lymphadenectomy alone for the detection of metastasis and the use of adjuvant therapies in patients with endometrial cancer .
post lymphadenectomy complications and quality of life among breast cancer patients in brazil. - pubmed - ncbi
was to compare the effects of drains versus no drains in preventing lymphocyst formation following pelvic lymphadenectomy .
lymphadenectomy in the management of stage i malignant melanoma: a prospective randomized study. - pubmed - ncbi
[ lymphadenectomy: indications - - technic - - invasion - - documentation ]. - pubmed - ncbi
this review found no evidence that lymphadenectomy decreases risk of death or disease recurrence compared with no lymphadenectomy in women with presumed stage i disease. evidence on serious adverse events suggests that women who undergo lymphadenectomy are more likely to experience surgery - related systemic morbidity or lymphoedema / lymphocyst formation. currently, no rct evidence shows the impact of lymphadenectomy in women with higher - stage disease and in those at high risk of disease recurrence .
caldwell, w. l. : why retroperitoneal lymphadenectomy for testicular tumors? sth. med. j .
zielinski m. technical pitfalls of transcervical extended mediastinal lymphadenectomy - - how to avoid them and to manage intraoperative complications .
sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. - pubmed - ncbi
to assess whether pelvic lymphadenectomy at surgical staging for endometrial carcinoma is an independent risk factor for the occurrence of postoperative complications .
patients received a standardized cervical injection of indocyanine green, followed by sentinel lymph node mapping and pelvic lymphadenectomy with or without para - aortic lymphadenectomy. sentinel lymph nodes that were negative on hematoxylin - and - eosin staining of sections were ultrastaged by immunohistochemistry for cytokeratin .
shimoyama s, seto y, yasuda h, kaminishi m. wider indications for the local resection of gastric cancer by adjacent lymphadenectomy .
the performance of sln mapping with staging lymphadenectomy increased the detection of lymph node metastasis and was associated with more use of adjuvant therapies .
to assess the effects of retroperitoneal drainage versus no drainage after pelvic lymphadenectomy on lymphocyst formation and related morbidities in women with gynaecological cancer .
zielinski m. transcervical extended mediastinal lymphadenectomy: results of staging in two hundred fifty - six patients with non - small cell lung cancer .
a comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (fires trial): a multicentre, prospective, cohort study .
a comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (fires trial): a multicentre, prospective, cohort study .
castro, j. r. : lymphadenectomy and radiation therapy in malignant tumors of the testicle other than pure seminoma. cancer (philad. )
a recent trend for less invasive surgery has increased consideration for a minimized scope of lymphadenectomy for submucosal cancer; however, feasibility criteria have not been precisely established .
a comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (fires trial): a multicentre, prospective, cohort study. - pubmed - ncbi
all patients with apparent early - stage endometrial cancer (n = 780) who underwent robotic - assisted hysterectomy with pelvic±aortic lymphadenectomy from july - 2006 to june - 2013 were compared [ pelvic±aortic lymphadenectomy (n = 661) versus sln - mapped cases with pelvic±aortic lymphadenectomy (n = 119) ]. isosulfan - blue and indocyanine - green with near - infrared imaging were used for sln mapping. clinico - pathological data, figo stage, gog risk category, and adjuvant therapies were compared .
hata e, haykawa k, miyamoto h, et al. rationale for extended lymphadenectomy for lung cancer. theor surg. 1990. 5: 19 - 25 .
zielinski m, hauer l, hauer j, nabialek t, szlubowski a, pankowski j. non - small - cell lung cancer restaging with transcervical extended mediastinal lymphadenectomy .
kuzdzal j, zielinski m, papla b, narski m, szlubowski a, hauer l, et al. effect of bilateral mediastinal lymphadenectomy on short - term pulmonary function .
sentinel lymph nodes identified with indocyanine green have a high degree of diagnostic accuracy in detecting endometrial cancer metastases and can safely replace lymphadenectomy in the staging of endometrial cancer. sentinel lymph node biopsy will not identify metastases in 3% of patients with node - positive disease, but has the potential to expose fewer patients to the morbidity of a complete lymphadenectomy .
sentinel lymph node mapping with complete pelvic lymphadenectomy was performed in 340 patients, including para - aortic lymphadenectomy in 196 patients (58 %). among these patients, 293 (86 %) had successful mapping of at least 1 sentinel lymph node. overall, 41 patients (12 %) had positive nodes, including 36 with ≥ 1 mapped sentinel lymph node .
the investigators concluded: “sentinel lymph nodes identified with indocyanine green have a high degree of diagnostic accuracy in detecting endometrial cancer metastases and can safely replace lymphadenectomy in the staging of endometrial cancer. sentinel lymph node biopsy will not identify metastases in 3% of patients with node - positive disease, but has the potential to expose fewer patients to the morbidity of a complete lymphadenectomy. ”
shimoyama s, joujima y, yasuda h, oohara t, kaminishi m. prospectively performed modified d1 lymphadenectomy for clinically diagnosed mucosal, node negative gastric cancer: our findings over the past decade .
two review authors independently extracted data and assessed risk of bias. hazard ratios (hrs) for overall and progression - free survival and risk ratios (rrs) comparing adverse events in women who received lymphadenectomy versus those with no lymphadenectomy were pooled in random - effects meta - analyses. we assessed the quality of the evidence using the grade (grades of recommendation, assessment, development and evaluation) approach .
kuzdzal j, zielinski m, papla b, urbanik a, wojciechowski w, narski m, et al. the transcervical extended mediastinal lymphadenectomy versus cervical mediastinoscopy in non - small cell lung cancer staging .
placement of retroperitoneal tube drains has no benefit in the prevention of lymphocyst formation after pelvic lymphadenectomy in women with gynaecological malignancies. when the pelvic peritoneum is left open, the tube drain placement is associated with a higher
complete mediastinal lymphadenectomy will continue to be performed in medical centers demanding the most comprehensive information. this is justified by previous data demonstrating that the dissection can be performed with minimal time and no increase in morbidity and mortality .
walsh, p. c. , kaufman, j. j. , coulson, w. f. , goodwin, w. e. : retro - peritoneal lymphadenectomy for testicular tumors. j. amer. med. ass .
stanford has been a leading center in advancing the use of laparoscopic lymphadenectomy since the early 1990s. doctors at the stanford cancer center have been among the first to use the procedure in prostate cancer, endometrial cancer, and other genitourinary cancers .
this knowledge helps doctors understand how advanced the cancer is, and thus how to treat it. although lymph nodes can be biopsied or removed during a surgical procedure, it is now often possible to use a less invasive approach called a laparoscopic lymphadenectomy .
laparoscopic lymphadenectomy can provide results equivalent to surgical biopsies or lymph node removal and, although it is carried out under general anesthesia, it is less invasive than surgery so your hospital stay will be shorter and you will recover much faster and with less pain .
leschber g, holinka g, linder a. video - assisted mediastinoscopic lymphadenectomy (vamla) - - a method for systematic mediastinal lymphnode dissection. eur j cardiothorac surg. 2003 aug. 24 (2): 192 - 5. [ medline ] .
published in issue 6, 2014. pelvic lymphadenectomy is associated with significant complications including lymphocyst formation and related morbidities. retroperitoneal drainage using suction drains has been recommended as a method to prevent such complications. however, findings from recent studies have challenged this policy .
hürtgen m, friedel g, toomes h, fritz p. radical video - assisted mediastinoscopic lymphadenectomy (vamla) - - technique and first results. eur j cardiothorac surg. 2002 feb. 21 (2): 348 - 51. [ medline ] .
nicholson, t. c. , wash, p. c. , ratner, m. b. : lymphadenectomy combined with preoperative and postoperative cobalt 60 teletherapy in the management of embryonal carcinoma and teratocarcinoma of the testis. j. urol. (baltimore )
during a laparoscopic lymphadenectomy the surgeon makes a small incision in the lower abdomen to reach the lymph nodes. a tiny tube with a light and a camera (i. e. , a laparoscope) is inserted into the incision and directed to the lymph nodes .
johnson d. e. (1977) retroperitoneal lymphadenectomy: indications, complications and expectations. in: grundmann e. , vahlensieck w. (eds) tumors of the male genital system. recent results in cancer research, vol 60. springer, berlin, heidelberg
in the fires prospective cohort study reported in the lancet oncology, emma c. rossi, md, of the university of north carolina, chapel hill, and colleagues found that sentinel lymph node mapping was highly accurate in detecting metastases compared with complete lymphadenectomy in women with endometrial cancer .
charoenkwan k, kietpeerakool c. retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies. cochrane database of systematic reviews 2017, issue 6. art. no. : cd007387. doi: 10. 1002 / 14651858. cd007387. pub4
a mediastinal lymphadenectomy may be performed to achieve complete staging (possibly to make postoperative treatment decisions), better locoregional control, and improved overall survival. arguments against the procedure include increased operating time, possible increased morbidity, and lack of conclusive evidence to support an increased survival from the procedure .
yoo dg, kim yh, kim dk, kim hr, park si. clinical feasibility and surgical benefits of video - assisted mediastinoscopic lymphadenectomy in the treatment of resectable lung cancer. eur j cardiothorac surg. 2011 dec. 40 (6): 1483 - 6. [ medline ] .
sentinel - lymph - node mapping has been advocated as an alternative staging technique for endometrial cancer. the aim of this study was to measure the sensitivity and negative predictive value of sentinel - lymph - node mapping compared with the gold standard of complete lymphadenectomy in detecting metastatic disease for endometrial cancer .
) that compared the effect of retroperitoneal drainage versus no drainage after pelvic lymphadenectomy in women with gynaecological cancer. retroperitoneal drainage was defined as placement of passive or active suction drains in pelvic retroperitoneal spaces. no drainage was defined as no placement of passive or active suction drains in pelvic retroperitoneal spaces .
mediastinal lymphadenectomy is indicated for t1 - 3 n0 - 1 resectable nsclc. patients should be without evidence of mediastinal lymph node involvement as assessed by preoperative imaging (ct, pet, or both) and sampling by means of mediastinoscopy, a chamberlain procedure, endoscopic ultrasonography, or a transbronchial technique .
maier, j. g. , buskirk, k. e. , van sulak, m. h. , perry, r. h. , schomber, d. t. : an evaluation of lymphadenectomy in the treatment of malignant testicular germ cell neoplasms. j. urol. (baltimore )
call s, obiols c, rami - porta r, trujillo - reyes jc, iglesias m, saumench r, et al. video - assisted mediastinoscopic lymphadenectomy for staging non - small cell lung cancer. ann thorac surg. 2016 apr. 101 (4): 1326 - 33. [ medline ] .
witte b, messerschmidt a, hillebrand h, gross s, wolf m, kriegel e, et al. combined videothoracoscopic and videomediastinoscopic approach improves radicality of minimally invasive mediastinal lymphadenectomy for early stage lung carcinoma. eur j cardiothorac surg. 2009 feb. 35 (2): 343 - 7. [ medline ] .
when submucosal cancer is evaluated as ct1cn0, a virtually sufficient minimized scope of lymphadenectomy is a d1 dissection for that within the cutoff diameter and a modified d2 dissection for that exceeding the cutoff diameter. these two types of dissection can even cover the infrequently observed node - positive stations and can realize no residual disease at surgery .
izbicki jr, passlick b, pantel k, pichlmeier u, hosch sb, karg o, et al. effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non - small cell lung cancer: results of a prospective randomized trial. ann surg. 1998 jan. 227 (1): 138 - 44. [ medline ] .
darling ge, allen ms, decker pa, ballman k, malthaner ra, inculet ri, et al. randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with n0 or n1 (less than hilar) non - small cell carcinoma: results of the american college of surgery oncology group z0030 trial .
wang x, yan s, phan k, yan td, zhang l, yang y, et al. mediastinal lymphadenectomy fulfilling nccn criteria may improve the outcome of clinical n0 - 1 and pathological n2 non - small cell lung cancer. j thorac dis. 2016 mar. 8 (3): 342 - 9. [ medline ]. [ full text ] .
patients receive radiolabeled technetium tc 99m sulfur colloid injected around the tumor 6 hours prior to or after induction of anesthesia right before surgery. patients then undergo radical hysterectomy and complete pelvic and low para - aortic lymphadenectomy. intraoperatively, patients undergo lymphatic mapping and sentinel lymph node identification using isosulfan blue or methylene blue injected at 4 locations in the cervix and a hand - held gamma counter .
a critical review of published literature on mediastinal lymphadenectomy requires an understanding of the described operative technique. sampling refers to the technique of removing easily found and obviously abnormal mediastinal lymph nodes. systematic sampling refers to the routine biopsy of lymph nodes at levels or stations as specified by the authors. complete mediastinal lymph node dissection refers to the routine complete removal of all mediastinal tissue as described by the authors .
dykhuizer, r. f. , george, f. w. , iii, kirohara, s. , ratner, m. , sargent, c. r. , varney, j. k. : the use of cobalt 60 telecurietherapy or x - ray therapy with and without lymphadenectomy in the treatment of testis germinal tumors; a 20 - year comparison study. j. urol. (baltimore )
the surgeon documented that she performed a partial mastectomy, sentinel node mapping, sentinel node biopsy and a complete lymphadenectomy. our question is directed at the sentinel node biopsy only as we are receiving denials for this procedure. we are reporting cpt code 38525 with 19302 and are receiving a denial as inclusive. we are not sure what modifier to use as the modifier 59 submitted on appeal is not bypassing our payor’s edit .
this is an often asked question. while the sentinel node biopsy is separately reportable with a partial mastectomy, the work is considered inclusive to the lymphadenectomy performed on the same day and is not separately reportable. the denial as inclusive to cpt code 19302 is correct. perform a write off on the account for cpt code 38792 as a coding error adjustment for tracking purposes. use this example as part of your compliance review .
the nci dictionary of cancer terms features 8, 287 terms related to cancer and medicine .
we offer a widget that you can add to your website to let users look up cancer - related terms. get nci’s dictionary of cancer terms widget .
the search textbox has an autosuggest feature. when you enter three or more characters, a list of up to 10 suggestions will popup under the textbox. use the arrow keys to move through the suggestions. to select a suggestion, hit the enter key. using the escape key closes the listbox and puts you back at the textbox. the radio buttons allow you to toggle between having all search items start with or contain the text you entered in the search box .
a surgical procedure to remove most or all of the lymph nodes that drain lymph from the area around a tumor. the lymph nodes are then examined under a microscope to see if cancer cells have spread to them .
the nci dictionary of cancer terms features 8, 239 terms related to cancer and medicine .
national medical specialty societies as well as organizations representing other members of the clinical care team are working with the abim foundation to help providers, patients and other health care stakeholders think and talk about overuse of health care resources in the united states .
specialty society partners are also expected to review and update their list on an annual basis to ensure that it continues to reflect the best evidence as well as review and update the list as needed upon publication of new evidence that contradicts one or more society recommendations .
by partnering in the choosing wisely campaign, aapm & r hopes that patients will initiate discussions with their physicians .
as the global leader in clinical chest medicine, the american college of chest physicians (chest) represents more than 18, 700 members who provide patient care in the areas of pulmonary, critical care, and sleep medicine in the united states and more than 100 countries worldwide. from cutting - edge medical research in the journal chest; evidence - based guidelines in antithrombotic therapy, lung cancer, and chronic cough; to innovative clinical education delivered through the chest annual meeting, simulation education program, and board review courses, chest strives to fulfill its mission – to promote the prevention, diagnosis, and treatment of chest diseases through education, communication, and research .
the american college of obstetricians and gynecologists (the college), representing over 56, 000 physicians and partners in women’s health, is proud to partner with the choosing wisely ® campaign. the college promotes quality, safety and efficiency in the delivery of women’s health care services. the college believes that the efforts of the choosing wisely campaign will directly contribute to these goals. recommendations that are based on specific medical evidence should be discussed between physicians and their patients to help make wise decisions about appropriate care. these efforts are particularly important since women are the primary decision makers for themselves and their families with regard to health care .
the american epilepsy society believes in the importance of engaging patients and providers in conversations that empower patients and lead to improved care. people living with epilepsy, a complex spectrum of disorders, connect with our health system in many different ways and across multiple areas. assuring not only that appropriate tests, procedures and treatments are offered but also that unnecessary interventions are avoided is critical to those living with one of the most common neurological disorders .
in support of our 16, 000 members who are committed to high - quality patient care, the american gastroenterological association (aga) is pleased to join the abim foundation and many other esteemed medical societies in the choosing wisely ® campaign. by developing clinical guidelines and quality measures, the aga ensures that the patient care decisions made by gastroenterologists are guided by scientific evidence. through the choosing wisely campaign, we hope to further increase physician and patient understanding of which tests and procedures will benefit which patients, and in doing so minimize the misuse of costly screening and diagnostic tests .
amda — the society for post - acute and long - term care medicine (amda) is proud to be a partner in the choosing wisely® campaign. amda, the national professional association of medical directors, attending physicians, and other professionals practicing long term care medicine, is dedicated to excellence in patient care. amda provides education, advocacy, information, and professional development to enable its 5, 000 - plus members to deliver quality long term care .
the american psychiatric association (apa), founded in 1844, is the world’s largest psychiatric organization. it is a medical specialty society representing more than 33, 000 psychiatric physicians from the united states and around the world. its member physicians work together to ensure humane care and effective treatment for all persons with mental disorders, including intellectual disabilities and substance use disorders. apa is the voice and conscience of modern psychiatry. participating in the choosing wisely ® campaign furthers apa’s mission to promote the highest quality care for individuals with mental disorders (including intellectual disabilities and substance use disorders) and their families .
the american society for apheresis (asfa) is an organization of physicians, scientists, and allied health professionals whose mission is to advance apheresis medicine for patients, donors and practitioners through education, evidence - based practice, research and advocacy. asfa represents a broad range of professionals involved in: donor apheresis, apheresis in transplantation, and therapeutic apheresis. asfa is proud to join the choosing wisely campaign and advance efforts to reduce waste and overuse in health care .
the american society for reproductive medicine (asrm), founded in 1944, is the oldest and largest society devoted to reproductive medicine in the world with approximately 8000 members. asrm is proud to partner with the choosing wisely ® campaign and its focus on encouraging a dialog between health care providers and patients. as the leading multidisciplinary organization dedicated to the advancement of the art, science, and practice of reproductive medicine worldwide, asrm attempts to educate both the public and its members about the best practices in the field and views this campaign as consistent with its goals. the society views this campaign as complementary to its development of evidence - based practice guidelines for its members and the translation of these guidelines into patient information materials for the public .
the american thoracic society’s mission is to improve health worldwide by advancing research, clinical care, and public health in respiratory disease, critical illness, and sleep disorders. founded in 1905 to combat tuberculosis, the ats is the world’s oldest respiratory society. while the scope of the society’s activities have expanded greatly, its founding philosophy–that disease is vanquished faster when knowledge is shared–remains a touchstone for its programs and people, including 15, 000 members. for more information, please visit urltoken .
the american urogynecologic society (augs) is proud to partner with the choosing wisely campaign. founded in 1979, augs is the premier non - profit organization representing more than 1, 800 members including practicing physicians, nurse practitioners, physical therapists, nurses and health care professionals, as well as researchers from many disciplines, all dedicated to treating female pelvic floor disorders .
as the leader in female pelvic medicine and reconstructive surgery, augs promotes the highest quality patient care through excellence in education, research and advocacy. participation in choosing wisely® complements augs’ commitment to quality improvement, and improving patient care practices and outcomes .
the heart rhythm society (hrs) is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. representing more than 5, 800 heart rhythm professionals in more than 70 countries around the world, hrs is pleased to partner in the choosing wisely ® campaign to help ensure that people living with heart rhythm disorders receive optimal care and improved quality of life. the society also is a leader of the “ apples and oranges ” sudden cardiac arrest awareness campaign aimed at sharing the differences between sca and heart attack and the “ afib feels like ” awareness campaign aimed at helping people understand the symptoms, risks, and treatment options for atrial fibrillation, the most common heart rhythm disorder. for more information, follow hrs on twitter, facebook, linkedin, or the society’s blog, ep insights .
hivma is pleased to partner with the choosing wisely® campaign to raise awareness of inappropriate, wasteful clinical actions that harm patients and lead to wasteful health costs. consistent with the mission of choosing wisely®, hivma is committed to evidence - based medicine and continually develops and updates clinical practice guidelines that inform the use of high - quality, truly necessary medicine .
founded in 2001, the society for the advancement of blood management (sabm) was started by a group of dedicated volunteers who saw a need for a new way of thinking. the sabm founders realized that blood management ought to be the standard of care, and that blood transfusion should be viewed as the alternative. today, sabm is recognized as a key educational resource for patient blood management. sabm is grounded in scientific validation, evidence - based practices and focused on promoting the patients’ best interest through effective and optimal blood management .
sabm defines its mission as the improvement of health outcomes by advancing comprehensive patient blood management practices, promoting innovative research, and providing quality professional and public education .
given our mission and message, sabm is truly honored and proud to partner with the choosing wisely® campaign .
as a leading voice in infection prevention and antibiotic stewardship, the society for healthcare epidemiology of america (shea) strongly supports the goals of the choosing wisely® campaign and is a proud to partner in helping raise awareness of inappropriate clinical actions that can harm patients and increase the cost of care. shea is a professional society representing physicians and other healthcare professionals around the world with expertise in healthcare epidemiology, infection prevention, and antibiotic stewardship. the society is on the forefront of the education, research, and guideline development for the appropriate and safe use of antibiotics, as well as clinical practices that reduce healthcare - associated infections, optimize patient safety, control costs, and reduce resistance to antimicrobials .
choosing wisely® is an initiative of the abim foundation. © 2018. all rights reserved .
html public
- / / w3c / / dtd xhtml 1. 0 strict / / en
urltoken
notice: users may be experiencing issues with displaying some pages on stanfordhealthcare. org. we are working closely with our technical teams to resolve the issue as quickly as possible. thank you for your patience .
access your health information from any device with myhealth. you can message your clinic, view lab results, schedule an appointment, and pay your bill .
the myhealth mobile app puts all your health information at your fingertips and makes managing your health care simple and quick. available for iphone and android .
when investigating pelvic cancers (such as prostate, testicular, cervical, and uterine cancers) it is important to know whether the disease has spread to the lymph nodes in the region .
the doctor navigates and inspects the region on a tv - like monitor that receives images from the camera, and can biopsy or remove the lymph nodes with a cutting instrument and tissue retrieval apparatus that is also part of the laparoscope .
in addition, the laparoscope images are magnified when they appear on the monitor, allowing your doctor to see even greater tissue detail than would be available during traditional surgery .
like all surgeries, the success of laparoscopic surgery is related to doctor' s experience with the technique. with well over a decade of experience, you can be assured that the stanford cancer center provides the reliable, quality care that is essential when you are facing cancer .
if a woman has symptoms of endometrial cancer, her doctor will examine her and possibly order blood and urine tests .
pelvic exam and pap smears, which look for cervical cancer, can also find a small number of endometrial cancers before symptoms develop .
transvaginal ultrasound, in which the doctor inserts a wand - like instrument into the vagina. the instrument aims high - frequency sound waves at the uterus. the pattern of the echoes they produce creates a picture. saltwater can be placed into the uterus through the cervix before the ultrasound test to give a clearer picture. this is called a sonohystogram. if the endometrium looks too thick or irregular, the doctor can perform an endometrial biopsy in the office or a dilation and curettage (d & c) in the operating room .
the definitive test is a biopsy (taking and testing a tissue sample from the uterus). if a biopsy confirms the diagnosis, the doctor will order imaging tests such as a ct scan or mri; blood tests for ca - 125, a marker seen both with ovarian and endometrial cancer; and a colonoscopy. the doctor may also order exploratory surgery (opening the abdomen) to determine how far the disease has spread .
if the cancer has spread beyond the uterus, then after surgery the patient is given radiation, often in combination with chemotherapy, to wipe out the remaining cancer cells. some doctors also recommend radiation when the tumor is large but has not spread beyond the uterus .
patients in remission need checkups every few months for several years. if cancer comes back, it usually happens within three years. caught early, cancer that comes back may be cured with aggressive radiation, chemotherapy, or more surgery .
to help cope with the emotional difficulties of having uterine cancer, patients might consider joining a support group. counseling is especially helpful for pre - menopausal women who become depressed after a hysterectomy .
lebovic, d. ; gordon, j. ; taylor, r. ;
reproductive endocrinology & infertility .
scrubb hill press, 2005 .
melanoma is a type of skin cancer. when it spreads to other places in your body, it' s called metastatic, or advanced. you may also hear your doctor refer to it as stage iv melanoma .
although in most cases it can' t be cured, treatments and support can help you live longer and better. doctors have new therapies that have greatly increased survival rates. and researchers are working to find new medications that can do even more .
remember: you still have control over the decisions you make about your treatment and your life. it' s important to have people you can talk to about your plans, your fears, and your feelings. so find support and learn about your treatment options. that will help you make the most of your life .
in most cases, melanoma is caused by exposure to ultraviolet (uv) radiation from the sun or tanning beds. it damages the dna of your skin cells, and they start to grow out of control .
you can get the disease on parts of your body that don' t get sunlight, though, like the palms of your hands and the retinas of your eyes .
if you haven’t already been diagnosed with melanoma, your doctor will do a skin exam. if he thinks you may have skin cancer, you' ll need a biopsy to find out .
a doctor will look at the growth under a microscope to see how thick it is. usually, a thicker tumor means the cancer is more serious .
if you' ve been diagnosed with melanoma, you may also have a blood test and an imaging test to see if it has spread to other areas .
chest x - ray. this uses radiation in low doses to make pictures of the inside of your body .
ct scan (computerized tomography). it uses powerful x - rays so your doctor can get a detailed look at what' s going on inside you .
mri (magnetic resonance imaging). it uses powerful magnets and radio waves to make pictures of organs and structures inside your body. it helps show blood flow and can help locate cancer growths .
pet scan. this test uses radioactive material to look for signs of cancer .
the doctor will also check to see if your lymph nodes are enlarged. lymph nodes are bean - sized glands under the skin in your neck, underarms, and groin. the doctor uses a thin needle to remove a sample of cells. this is called a fine - needle aspiration biopsy .
the doctor may also do a lymph node biopsy. this removes the lymph nodes most likely to have cancer cells. in this test, the doctor injects a dye into the area where the potential cancer was. it spreads to the nearest lymph nodes, which are removed and tested. if these lymph nodes, called sentinel nodes, don' t have cancer, then it' s likely the cancer hasn' t spread .
the results of these tests help the doctor determine the stage of your cancer and how widespread it is .
you and your doctor will decide on the best treatment plan once you know that information .
although metastatic melanoma is not easy to treat, you do have options. choosing what' s right for you will depend on where and how big the cancer is, what your health is like, and what your wishes are. since most cases of metastatic melanoma can' t be cured, the goals of treatment are to :
treatment used to be mainly radiation and chemotherapy. now there are newer drugs available that can work better, studies show. your treatment may include :
surgery. your doctor may remove tumors or lymph glands. although surgery alone probably won' t cure the cancer, it can help you live longer and have fewer symptoms. your doctor will likely also use one or more other treatments .
radiation and chemotherapy. these can help some people, depending on the size and location of the cancer .
immunotherapy. these drugs boost your immune system so it can better attack the cancer. you get immunotherapy through an iv or a shot in high doses. it can have serious side effects, but it can also shrink metastatic melanomas and help some people live longer. these drugs include :
interferon - alpha and interleukin - 2: these older drugs can help some people live longer .
ipilimumab (yervoy): there are two uses for this drug. it can be given to individuals who have had surgery to remove melanoma in order to prevent the melanoma from coming back. it can also be used for late - stage melanoma that cannot be removed by surgery. but the drug doesn' t work for everyone, and it can have serious, even life - threatening, side effects .
nivolumab (opdivo): it works by inhibiting the pd - 1 protein on cells, which blocks the body’s immune system from attacking melanoma tumors. it' s been shown to increase overall survival .
pembrolizumab (keytruda): in people with advanced melanoma who have already been treated with yervoy, keytruda may shrink tumors in some. you take it as an iv infusion every 3 weeks .
researchers are studying many other drugs that spur the immune system to fight melanoma. because metastatic melanoma is so hard to treat, you may want to ask your doctor about taking part in a clinical trial, which uses a treatment that' s still under research .
targeted therapy. this kind of treatment aims to kill cancer cells without harming healthy ones. they may work for people who have certain changes in genes. because these treatments target the tumors, they may cause fewer side effects than chemotherapy or radiation .
some drugs attack a gene called braf. about half the people who have melanoma have changes in this gene, which helps cancer cells grow. if you have a tumor with braf, these drugs may shrink it and extend your life. they include :
other drugs block an enzyme called mek. this enzyme is often overactive in some cancers. these drugs, working in combination with a braf inhibitor to attack cancer cells, seem to shrink tumors for a longer period of time :
hearing that your cancer has spread is scary, but a lot of research is underway to find new treatments. and there are treatments available to try to stop the disease from spreading, so you can live longer .
it' s important to have support and to talk about your fears and feelings, too. your doctor can help you find a cancer support group .
if you lose your appetite, eat small amounts of food every 2 to 3 hours instead of bigger meals. a dietitian can give you other tips on nutrition and eating during your cancer treatment. ask your doctor for a referral .
exercise can help you feel better overall and fight fatigue. but listen to your body, and balance rest and activity .
get the kind of emotional support that' s right for you. it could be from family, friends, your cancer support group, or a religious group .
although stage iv melanoma is hard to treat, each case is different, and some people will respond very well to treatment. talk to your doctor about all your options, and find out more about clinical trials to see if one is right for you .
the melanoma research foundation has an online library of free support services, including an online patient community and a phone buddy program. and for more information on metastatic melanoma, go to the web site of the skin cancer foundation .
if you are interested in more advanced reading on this topic, we’ve made content from our health professional site, medscape, available to you on webmd .
american cancer society :
melanoma skin cancer overview ,
treatment of melanoma sin cancer by stage, ”
targeted therapy for melanoma skin cancer .
fda :
fda approves yervoy to reduce the risk of melanoma returning after surgery ,
fda approves cotellic as part of combination treatment for advanced melanoma .
national cancer institute :
what you need to know about melanoma and other skin cancers .
medscape: “some melanoma patients living for up to 10 years after ipilimumab. ”
uptodate :
melanoma treatment; advanced or metastatic melanoma (beyond the basics) .
html public
- / / w3c / / dtd xhtml 1. 0 transitional / / en
urltoken
warning: the ncbi web site requires javascript to function. more ...
cochrane database syst rev. 2015 sep 21; (9): cd007585. doi: 10. 1002 / 14651858. cd007585. pub3 .
obstetrics and gynaecology, gloucestershire hospitals nhs foundation trust, great western road, gloucester, uk, gl1 3nn .
we searched the cochrane central register of controlled trials (central), the cochrane gynaecological cancer review group trials register, medline and embase to june 2009 for the original review and extended the search to june 2015 for this version of the review. we also searched registers of clinical trials, abstracts of scientific meetings and reference lists of included studies, and we contacted experts in the field .
please confirm that you would like to log out of medscape. if you log out, you will be required to enter your username and password the next time you visit. log out cancel
author: r james koness, md, facs; chief editor: erik d schraga, md more ...
the classification of regional lymph node stations for lung cancer staging reported by mountain and dresler in 1997 describes the anatomic landmarks for 14 levels of intrapulmonary, hilar, and mediastinal lymph nodes stations. [ 5 ] tnm classification for lung cancer classifies lymph node stations into six zones, as follows :
n3 lymph nodes are contralateral mediastinal, ipsilateral scalene, or supraclavicular. among the primary tumors that had only a single involved n2 station, the most common site of lymph node metastases was level 4r for right - upper - lobe tumors, levels 5 / 6 for left - upper - lobe tumors, and level 7 for middle - and lower - lobe tumors. [ 6 ]
four published randomized trials compared mediastinal lymph node dissection and mediastinal lymph node sampling. [ 7, 8, 9, 10 ] a meta - analysis of the first three trials reported a survival advantage for stages i, ii, and iiia, and a fixed - effects model by the same group reported that mediastinal lymph node dissection reduced the risk of death. [ 11, 12 ]
call et al assessed the results of vamla for staging nsclc in 160 cases, 138 of which involved clinical n0 - 1 cancers. [ 13 ] they found vamla to be highly accurate, with a sensitivity of 0. 96 (95% confidence interval [ ci ], 0. 81 - 99. 3), a specificity of 1 (95% ci, 0. 97 - 1), a positive predictive value of 1 (95% ci, 0. 87 - 1), a negative predictive value of 0. 99 (95% ci, 0. 95 - 0. 99), and a diagnostic accuracy of 0. 99 (95% ci, 0. 96 - 0. 99). complications developed in 5. 9% of patients .
cahan wg, watson wl, pool jl. radical pneumonectomy. j thorac surg. 1951 nov. 22 (5): 449 - 73. [ medline ] .
little ag, rusch vw, bonner ja, gaspar le, green mr, webb wr, et al. patterns of surgical care of lung cancer patients. ann thorac surg. 2005 dec. 80 (6): 2051 - 6; discussion 2056. [ medline ] .
ginsberg rj. resection of non - small cell lung cancer: how much and by what route. chest. 1997 oct. 112 (4 suppl): 203s - 205s. [ medline ] .
mountain cf, dresler cm. regional lymph node classification for lung cancer staging. chest. 1997 jun. 111 (6): 1718 - 23. [ medline ] .
rusch vw, crowley j, giroux dj, goldstraw p, im jg, tsuboi m, et al. the iaslc lung cancer staging project: proposals for the revision of the n descriptors in the forthcoming seventh edition of the tnm classification for lung cancer. j thorac oncol. 2007 jul. 2 (7): 603 - 12. [ medline ] .
sugi k, nawata k, fujita n, ueda k, tanaka t, matsuoka t, et al. systematic lymph node dissection for clinically diagnosed peripheral non - small - cell lung cancer less than 2 cm in diameter. world j surg. 1998 mar. 22 (3): 290 - 4; discussion 294 - 5. [ medline ] .
wu yl, huang zf, wang sy, yang xn, ou w. a randomized trial of systematic nodal dissection in resectable non - small cell lung cancer. lung cancer. 2002 apr. 36 (1): 1 - 6. [ medline ] .
wright g, manser rl, byrnes g, hart d, campbell da. surgery for non - small cell lung cancer: systematic review and meta - analysis of randomised controlled trials. thorax. 2006 jul. 61 (7): 597 - 603. [ medline ] .
manser r, wright g, hart d, byrnes g, campbell da. surgery for early stage non - small cell lung cancer. cochrane database syst rev. 2005 jan 25. cd004699. [ medline ] .
naruke t. mediastinal lymph node dissection. general thoracic surgery. 6th ed. philadelphia: lippincott williams & wilkins; 2005 .
martini n. mediastinal lymph node dissection for lung cancer. the memorial experience. chest surg clin n am. 1995 may. 5 (2): 189 - 203. [ medline ] .
watanabe y, shimizu j, tsubota m, iwa t. mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. mediastinal nodal metastases in lung cancer. chest. 1990 may. 97 (5): 1059 - 65. [ medline ] .
whitson ba, groth ss, duval sj, swanson sj, maddaus ma. surgery for early - stage non - small cell lung cancer: a systematic review of the video - assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. ann thorac surg. 2008 dec. 86 (6): 2008 - 16; discussion 2016 - 8. [ medline ] .
yan td, black d, bannon pg, mccaughan bc. systematic review and meta - analysis of randomized and nonrandomized trials on safety and efficacy of video - assisted thoracic surgery lobectomy for early - stage non - small - cell lung cancer. j clin oncol. 2009 may 20. 27 (15): 2553 - 62. [ medline ] .
cerfolio rj, bryant as, eloubeidi ma. accessing the aortopulmonary window (# 5) and the paraaortic (# 6) lymph nodes in patients with non - small cell lung cancer. ann thorac surg. 2007 sep. 84 (3): 940 - 5. [ medline ] .
video - mediastinoscope (wolf company, knittlingen, germany), with the 2 blades opened for demonstration .
r james koness, md, facs program director, fellowship in surgical oncology, roger williams medical center; clinical assistant professor, division of surgical oncology, department of surgery, the warren alpert medical school of brown university r james koness, md, facs is a member of the following medical societies: american college of surgeons, american head and neck society, society of surgical oncology, american society of breast surgeons disclosure: nothing to disclose .
erik d schraga, md staff physician, department of emergency medicine, mills - peninsula emergency medical associates disclosure: nothing to disclose .
all material on this website is protected by copyright, copyright © 1994 - 2018 by webmd llc. this website also contains material copyrighted by 3rd parties .
urol clin north am. 2001 aug; 28 (3): 491 - 8 .
scott department of urology, baylor college of medicine, houston, texas, usa .
accurate mediastinal staging is the hallmark of a good thoracic oncology program. despite advancements in imaging, surgical staging remains the gold standard of mediastinal staging for lung cancer. this review article summarizes the technique of transcervical mediastinal lymph node dissection and its role in the staging of non - small cell lung cancer (nsclc) .
a transverse collar incision is made about 1 cm superior to the sternal notch to a length of 6–8 cm. bilateral anterior jugular veins are divided and subplatysmal flaps are developed superiorly and inferiorly with the upper flap reaching the level of the thyroid cartilage and the lower flap extending below the margin of the sternal notch (fig .
operative photograph showing the transverse cervical incision to accomplish temla. subplatysmal flaps have been raised and the strap muscles are being separated
in this operative photograph, the rultract retractor hook has been placed retrosternally and the sternum has been elevated. the innominate has been dissected and the right paratracheal space accessed
). this extensive dissection also facilitates thoracoscopic lobectomy / pneumonectomy as well as saves time by avoiding the need to dissect these stations by vats .
dissection of the deep right paratracheal space. after the lymph node packet is removed, the distal trachea and azygous vein can be clearly visualized
). occasionally, patients have thoracic inlets mobile and open enough to permit direct viewing of the distal tracheobronchial dissection .
in summary, temla is a promising technique that deserves multi - institutional evaluations for enhanced staging and in approaching the mediastinum for other pathology. future studies are needed to determine whether temla improves patient selection or survival with regards to lung cancer resection .
j thorac oncol: off publication of the international association for the study of lung cancer .
eur j cardiothorac surg: official journal of the european association for cardio - thoracic surgery .
) has remained the popular choice. the purpose of this presentation is to report our experience gained from performing 152 retro - peritoneal lymphadenectomies over the past 18 years and is an attempt at the present time to answer caldwell’s (
these keywords were added by machine and not by the authors. this process is experimental and the keywords may be updated as the learning algorithm improves .
boden, g. , gibb, r. : radiotherapy and testicular neoplasms. lancet (1951 )
dean, a. l. : treatment of testis tumors. j. urol. (baltimore )
dees, j. e. : metastatic embryonal cell carcinoma of testis: an apparent 8 - year cure. j. urol. (baltimore )
lymphadenectomy or lymph node dissection is the surgical removal of one or more groups of lymph nodes . it is almost always performed as part of the surgical management of cancer . in a regional lymph node dissection , some of the lymph nodes in the tumor area are removed ; in a radical lymph node dissection , most or all of the lymph nodes in the tumor area are removed . 
lymphadenectomy or lymph node dissection is the surgical removal of one or more groups of lymph nodes. it is almost always performed as part of the surgical management of cancer. in a regional lymph node dissection, some of the lymph nodes in the tumor area are removed; in a radical lymph node dissection, most or all of the lymph nodes in the tumor area are removed.
lymphadenectomy or lymph node dissection is the surgical removal of one or more groups of lymph nodes. it is almost always performed as part of the surgical management of cancer. in a regional lymph node dissection, some of the lymph nodes in the tumor area are removed; in a radical lymph node dissection, most or all of the lymph nodes in the tumor area are removed.